Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where is that bigmouth big bambino . He has been awfully quiet . Probably because like I said you have fda approval and it cannot get above 5 dollars . Once again I am not shorting this stock I have not and never will short any stock but also once again I will not say a good word about how terrible this company is being ran . And also because I already lost a lot of money on this stock .
Wow …. This will be down to nothing soon … this company will never be worth shit because the people running it do not want it to be . I lost money back when this company did what it is doing now . No im not shorting this stock but I’m also not going to say anything good about this company . But you have delusional idiots on this board who think this is going up to a hundred . I don’t want to see what happened to me happen to others . I’m tired of management being the only ones making money
Ok that’s funny I’ll stop my nonsense .they are going to get a buy out for billions with sales that are not even one million. The truth hurts !
Stop your nonsense. They finally have revenues! Now it's only about growing pains, hopefully.
>>08:59 AM EDT, 08/08/2024 (MT Newswires) -- Geron (GERN) reported a Q2 net loss Thursday of $0.10 per diluted share, widening from a loss of $0.09 a year earlier.
Analysts polled by Capital IQ expected a per-share loss of $0.10.
Revenue for the quarter ended June 30 was $882,000, up fro $29,000 a year earlier.
Analysts surveyed by Capital IQ expected $290,000.
As of June 30, the company said it had $430.4 million in cash, cash equivalents and marketable securities, which, together with projected revenue from US sales of Rytelo, will be enough to fund its expected operating requirements into Q2 of 2026.
Well sorry to people who thought this was going somewhere… unfortunately the shorts are going to win this one .
Someone placed 19k on this weeks' 5 call options....They expect at least 5.10 in two days.
I have never seen a stock that cannot hold gains … it’s sad
Lots of call options trading today!
Someone truly likes the Jan 7 options!!
Oh boy this is going to get smashed today
"Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS"
I wish I had bought every dip this year. But I loaded up on CDs instead.
Still holding 3 positions.
LOL...A guy? You mean the Chief of Commercialization. Of course that's why it's down.
>>This collaspe is not because of a guy leaving the company
This collaspe is not because of a guy leaving the company it’s because they have nothing new to offer and fda approval was an abject failure.and investors are scared
You just told people here he holds his shares when there's a Form 4 showing he sold and still holds some shares. I suspect you simply don't know how to read filings.
Curve, I'm not giving out bad information. No one knows how many shares are still held by individuals. I'm also not disputing the sales of executives. That being said, no one knows why people sell shares. No one is expected to hold on forever, that is why we invest.
BigBambino giving out bad information. In fairness a number of execs sold around the same time on FDA approval. What's he have left about 170k shares?
All I'm saying is, when I pull out of stock (whether with a loss or gain) I move on to my other or future holdings. To hang around a board and post regularly for years only to post negative views is basically concerning. To sell shares at a loss, deserves a negative response. But to hang around for years, with no skin in the game tends to send up red flags as to why. I myself being a long, will only view further post and restrain from engaging any further. Best of luck to all longs, which I believe will be rewarded. Seeing as we've already regained 5% back from loss's, let's wait and see 😀
That's what I suggested earlier. Almost seems too obvious so I'm skeptical...But hopeful.
On June 10 of this year kapur sold 421,875 shares @$4.64…. Go to geron insider trading all activity is posted there ….not a good sign imo
Maybe this was a decision with a possible takeover. Go and look for an alternate position somewhere else, since they wouldn't need 2 in that position. I think how the stocks end's up after Friday, may tell us a little more.
Not me. Geron has way too loooong a history of torturing shareholders. Waiting to see some actual market penetration.
Hard to imagine why a Chief of commercialization would walk away right as they begin to commercialize?? Talk about spooking investors. Well, atleast they seem to have a capable back up on the BOD.
Your right. I myself think someone (like myself) is looking to pick up some really cheap shares. Only time will tell, but is surely interesting 😀
It almost seems like a set up to "shake the tree". But this is Geron after all, so who really knows.
let's not forget, he may have put in a resignation, but still holds his shares. If you can show me he sold all his shares, then maybe, maybe I would be concerned.
This is a bonus buying opportunity, just purchased another 1500 @ $4.26. So everyone knows how much I'm invested here. There is no way an FDA approved, life changing drug should be going down. To go down 10% on only 5m shares is a direct indication of who is controlling this. Wishing the longs all the future best that we shall see. If you are looking for a quick buck, than day trade. If your looking for a big payout, which I am, then we should hold.
Grrrrrron. Always such an uphill battle. Well, maybe he knows a buyout is coming??
"Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024"
Forgot to mention, will use that found money to purchase more today 😁
I hope my fellow long share holders filled out there form for the class action. I received a check for $7300 for my shares of period in 2018. That alone has made up a good chunk of my initial shares (which is paid for 10x's over). To have this at almost $5, still without any direction is phenomenal. if following trading sequence will notice, downward pressure is with share purchase of less then 100 shares. When direction is announced, this should go skyward. ALL JMHO and wish the best for all long's, GOD bless.
GERN is 30x the size of MAIA. Wouldn't be a merger, would be an acquisition.
Who is MAIA?
3 trades totaled 5.2m shares....something is up....Perhaps news on Monday or Tuesday
The shorts will never let this stock ever go up … it’s sad when you get fda approval and that is not even close to being enough . A buy out will be the only thing that makes this stock go
It’s a disgrace what management has done to this company it could have been a great stock ..
I’m pissed and I sold a long time ago for a loss but in retrospect it looks like this has no bottom and not another ounce of any news to lift it any time soon if at all . Absolutely disastrous results after approval .
Agree let’s get that buyout moving 💰💵
Looks like the 4k I purchased (from the guidance of a nameless lady) along with my other 23k @ $1.80 appx, is starting to really look good. now to just sit back, watching Missy grow 🤣🤣
Wow! This is just sad no other way to see it
My thoughts remain if Gern gets bought out and hopefully they will….I feel INCY is the ideal candidate…..they are constantly buying other companies….and I won’t be surprised if was a stock swat instead of a cash offer…..JMO
So what is the future worth of GERN?
My guess between $11 -$13 share ($6.5B -$8B)
Market size for MDS:
Global MDS Treatment Market: Estimates suggest the global MDS treatment market was valued at around:
$3.2 - $3.5 billion in 2022 [Sources: Coherent Market Insights, Credence Research]
It's expected to grow at a Compound Annual Growth Rate (CAGR) of:
5.56% - 9.5% by 2032 [Sources: Coherent Market Insights, Credence Research, Market.us]
Focus on MDS Drugs: If the focus is solely on MDS drugs, the market size was estimated at:
$2.39 billion in 2022 [Market.us]
Projected to reach $5.79 billion by 2032 with a CAGR of 9.5% [Market.us]
Factors Driving Market Growth:
Rising prevalence of MDS due to an aging population
Growing awareness and improved diagnosis of MDS
Introduction of novel drugs for treatment
Increasing research on bone marrow transplantation
Saw that. Nice little run. Get the deal done over the weekends perhaps??
yep...something is happening.
Appx 3.5m shares traded in the last 20 minutes and then BANG 14M. block at the close.
No rebalancing on funds that I am aware so this must mean something come Monday....
How to see BO at $10+...
Sorry I mean you are correct … I have turned spell check off on my phone more times than I can count
Followers
|
253
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7768
|
Created
|
03/25/03
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |